Clinical

Dataset Information

0

Prospective study on clinical practice using ultra magnifying endoscope and artificial intelligence -regarding diagnostic accuracy and image acquisition rate of colorectal tumor and cancer-


ABSTRACT: Primary outcome(s): This trial will be triple primary endpoint clinical trial. 1.When EC-CAD was used under methylene blue staining for polyps of 5 mm or less in diameter in the sigmoid colon from the rectum, it was verified that the result diagnosed with high confidence (probability 90% or more) was NPV 90% or more. 2.When observing a polyp of 5 mm or less in diameter with magnifying narrow band imaging (NBI) and NBI combined endocytoscopy (EC-NBI), verify that the ratio at which trainee can acquire a focused endoscope video for 3 seconds or more at EC-NBI. 3.When EC-CAD is used under methylene blue staining for colon lesions of 20 mm or more in diameter, we verify that the diagnostic ability for invasive cancer is over 90% PPV.

DISEASE(S): Colorectal Tumor And Cancer

PROVIDER: 2642573 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2723700 | ecrin-mdr-crc
| 2387981 | ecrin-mdr-crc
2009-03-28 | E-MEXP-2100 | biostudies-arrayexpress
2011-11-09 | E-GEOD-33553 | biostudies-arrayexpress
2019-01-16 | GSE117676 | GEO
| 2374158 | ecrin-mdr-crc
2007-02-22 | GSE6876 | GEO
2018-01-17 | E-MTAB-5933 | biostudies-arrayexpress
2018-02-09 | E-MTAB-6470 | biostudies-arrayexpress
| 2119387 | ecrin-mdr-crc